A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
Alexandre Harari(Ludwig Cancer Research), Lana E. Kandalaft(Ludwig Cancer Research)
Cited by 9
Related Papers
Whole Tumor Antigen Vaccines: Where Are We?
|Vaccines|2015|269
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer
|Nature Communications|2018|166
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes
|Cell Systems|2023|114
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
|Nature Communications|2023|66
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
|Cell Reports Methods|2023|48